Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
King's College London, Institute of Psychiatry, Psychology & Neuroscience, Social, Genetic & Developmental Psychiatry Centre, London, UK.
Eur Neuropsychopharmacol. 2018 Oct;28(10):1059-1088. doi: 10.1016/j.euroneuro.2018.08.001. Epub 2018 Sep 6.
Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder does not remit in puberty, but persists into adulthood. Both in childhood and adulthood, ADHD is characterised by substantial comorbidity including substance use, depression, anxiety, and accidents. However, course and symptoms of the disorder and the comorbidities may fluctuate and change over time, and even age of onset in childhood has recently been questioned. Available evidence to date is poor and largely inconsistent with regard to the predictors of persistence versus remittance. Likewise, the development of comorbid disorders cannot be foreseen early on, hampering preventive measures. These facts call for a lifespan perspective on ADHD from childhood to old age. In this selective review, we summarise current knowledge of the long-term course of ADHD, with an emphasis on clinical symptom and cognitive trajectories, treatment effects over the lifespan, and the development of comorbidities. Also, we summarise current knowledge and important unresolved issues on biological factors underlying different ADHD trajectories. We conclude that a severe lack of knowledge on lifespan aspects in ADHD still exists for nearly every aspect reviewed. We encourage large-scale research efforts to overcome those knowledge gaps through appropriately granular longitudinal studies.
注意缺陷多动障碍(ADHD)具有高度遗传性,是儿童期最常见的神经发育障碍。近几十年来,人们已经认识到,在相当多的病例中,这种疾病不会在青春期缓解,而是持续到成年。无论是在儿童期还是成年期,ADHD 都伴有大量的共病,包括物质使用、抑郁、焦虑和意外事故。然而,该疾病的病程和症状以及共病可能会随时间波动和变化,甚至儿童期的发病年龄最近也受到了质疑。迄今为止,可用的证据很少,而且在很大程度上不一致,无法预测疾病的持续存在或缓解。同样,共病的发展也无法早期预见,这阻碍了预防措施的实施。这些事实都呼吁从儿童期到老年对 ADHD 进行全生命周期的研究。在本次选择性综述中,我们总结了目前关于 ADHD 的长期病程的知识,重点介绍了临床症状和认知轨迹、全生命周期的治疗效果以及共病的发展。此外,我们还总结了目前关于 ADHD 不同病程背后的生物学因素的知识和重要的未解决问题。我们得出结论,几乎每一个被综述的方面都存在严重缺乏 ADHD 全生命周期方面知识的问题。我们鼓励通过适当的纵向研究,开展大规模的研究工作,以克服这些知识空白。